Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

Clinical Trial ID NCT00582673

PubWeight™ 2.34‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00582673

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential. Neuropharmacology 2010 1.30
2 AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Mov Disord 2011 1.10
Next 100